214 related articles for article (PubMed ID: 19647114)
1. The endocannabinoid anandamide from immunomodulation to neuroprotection. Implications for multiple sclerosis.
Correa FG; Mestre L; Docagne F; Borrell J; Guaza C
Vitam Horm; 2009; 81():207-30. PubMed ID: 19647114
[TBL] [Abstract][Full Text] [Related]
2. The endocannabinoid system in neurodegeneration.
Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
Ital J Biochem; 2006; 55(3-4):283-9. PubMed ID: 17274532
[TBL] [Abstract][Full Text] [Related]
3. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis.
Maccarrone M; Finazzi-Agró A
Cell Death Differ; 2003 Sep; 10(9):946-55. PubMed ID: 12934069
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells.
Correa F; Hernangómez-Herrero M; Mestre L; Loría F; Docagne F; Guaza C
Brain Behav Immun; 2011 May; 25(4):736-49. PubMed ID: 21310228
[TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid signaling system: pharmacological and therapeutic aspects.
Fowler CJ; Holt S; Nilsson O; Jonsson KO; Tiger G; Jacobsson SO
Pharmacol Biochem Behav; 2005 Jun; 81(2):248-62. PubMed ID: 15935456
[TBL] [Abstract][Full Text] [Related]
7. Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors.
Chiurchiù V; Leuti A; Cencioni MT; Albanese M; De Bardi M; Bisogno T; Centonze D; Battistini L; Maccarrone M
Pharmacol Res; 2016 Nov; 113(Pt A):313-319. PubMed ID: 27616551
[TBL] [Abstract][Full Text] [Related]
8. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
Fride E
Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
[TBL] [Abstract][Full Text] [Related]
9. An introduction to the endocannabinoid system: from the early to the latest concepts.
De Petrocellis L; Di Marzo V
Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoids and their involvement in the neurovascular system.
Battista N; Fezza F; Maccarrone M
Curr Neurovasc Res; 2004 Apr; 1(2):129-40. PubMed ID: 16185189
[TBL] [Abstract][Full Text] [Related]
11. Is GPR55 an anandamide receptor?
Brown AJ; Robin Hiley C
Vitam Horm; 2009; 81():111-37. PubMed ID: 19647110
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.
Mestre L; Correa F; Arévalo-Martín A; Molina-Holgado E; Valenti M; Ortar G; Di Marzo V; Guaza C
J Neurochem; 2005 Mar; 92(6):1327-39. PubMed ID: 15748152
[TBL] [Abstract][Full Text] [Related]
13. Anandamide receptor signal transduction.
Goodfellow CE; Glass M
Vitam Horm; 2009; 81():79-110. PubMed ID: 19647109
[TBL] [Abstract][Full Text] [Related]
14. Psychopharmacology of the endocannabinoids: far beyond anandamide.
Pamplona FA; Takahashi RN
J Psychopharmacol; 2012 Jan; 26(1):7-22. PubMed ID: 21652605
[TBL] [Abstract][Full Text] [Related]
15. Detergent-resistant membrane microdomains in the disposition of the lipid signaling molecule anandamide.
McFarland MJ; Terebova EA; Barker EL
AAPS J; 2006 Mar; 8(1):E95-100. PubMed ID: 16584138
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells.
Eljaschewitsch E; Witting A; Mawrin C; Lee T; Schmidt PM; Wolf S; Hoertnagl H; Raine CS; Schneider-Stock R; Nitsch R; Ullrich O
Neuron; 2006 Jan; 49(1):67-79. PubMed ID: 16387640
[TBL] [Abstract][Full Text] [Related]
17. Regulation of neural progenitor cell fate by anandamide.
Soltys J; Yushak M; Mao-Draayer Y
Biochem Biophys Res Commun; 2010 Sep; 400(1):21-6. PubMed ID: 20691161
[TBL] [Abstract][Full Text] [Related]
18. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis.
Centonze D; Bari M; Rossi S; Prosperetti C; Furlan R; Fezza F; De Chiara V; Battistini L; Bernardi G; Bernardini S; Martino G; Maccarrone M
Brain; 2007 Oct; 130(Pt 10):2543-53. PubMed ID: 17626034
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoids: synthesis and degradation.
Di Marzo V
Rev Physiol Biochem Pharmacol; 2008; 160():1-24. PubMed ID: 18481028
[TBL] [Abstract][Full Text] [Related]
20. [The endocannabinoid system and food intake control].
Rodríguez de Fonseca F
Rev Med Univ Navarra; 2004; 48(2):18-23. PubMed ID: 15382609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]